2024 Agenda
Wednesday October 23, 2024
Time
Topic
Thursday October 24, 2024
Time
Topic
Time
Topic
Kickoff & Keynotes
Dee Anna Smith
2:00-3:00pm
Case Studies: Oncology
Successful multi-stakeholder collaboration in genomic testing infrastructure
3:00-3:45
Oncology Panel: Emerging prominence of diagnostics & lagging adoption
Genomic lab spend and utilization will almost certainly rise for oncology patients, driven by innovations in genomic profiling, residual disease testing, and screening for new/metastatic disease. Paradoxically, adoption of proven diagnostics remains inconsistent. Many patients with non-small cell lung cancer still do not get tumor profiling. Where are diagnostics driving quality and value? What are the barriers to widespread adoption, and what is showing promise to overcome those barriers?
Lucy Langer, Mia Levy, Lalan Wilfong
4:00-5:00
Welcome Reception
Kimpton Aertson Hotel, Woodlea (17th Floor / Rooftop)
6:00-8:30
Breakfast
Kimpton Aertson, 8th Floor
7:00am
Kickoff Day 2
8:00-8:15
Case Studies: Women’s Health
Successful multi-stakeholder collaborations in advanced diagnostics
8:15-8:45
Panel: Women’s Health and Advanced Diagnostics
What’s happening at the intersection of advanced diagnostics and women’s health? Are there opportunities to use diagnostics to tackle underrecognized health conditions and reduce disparities in maternal mortality, cancers of the reproductive organs, and/or quality-of-life limiting conditions like uterine fibroids?
Joanne Armstrong, Digna Velez Edwards
8:45-9:45
Panel: The Business of Advanced Diagnostics
The lab market has been turbulent. This panel will explore what exactly has happened, why, and what it means for future development, the lab business, and access to advanced diagnostics.
Paul Diaz, Avi Kometz, Doug Schenkel
10:15-11:15
11:15-12:45pm
12:45-1:00
Lunch & Discussion
Recap & Afternoon Kickoff
Regulatory & Governance Perspectives
Insight on FDA, CMS, and the evolving regulatory and legislative environment for advanced diagnostics.
Alberto Gutierrez
1:00-2:00
Case Studies: Rare Disease
Successful multi-stakeholder collaboration in genetic testing infrastructure
2:15-2:30
Panel: Rare Disease
How has this space matured over the last 5 years, and where’s it going? How is the maturation of pathways for cell and gene therapy changing thinking about coverage of diagnostics and therapeutics? What are we learning from the introduction of gene therapies such as those for Sickle Cell Disease?
Gillian Hooker, Nancy Mendelsohn, Sharon Terry
2:30-3:30
Closing Panel: Observations, Insights & Actions
A high-impact summary of key takeaways from the meeting and recommended actions for the group
Mike Astion, Susan Hahn, Surya Singh
3:45-4:30
Music City at Night
Location TBA in Downtown Nashville
Transportation provided from the hotel
6:30-9:00
Friday October 25, 2024
Breakfast & Meetings (Optional)
Kimpton Aertson, 8th Floor
Breakfast will be served and meeting space is available for participants to discuss projects and ideas raised during the conference.
8:00-11:00am